GC
AGN

Guggenheim Capital’s Allergan Inc AGN Stock Holding History

Guggenheim Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-312,495
Closed -$66.4M – 3159
2014
Q4 		$66.4M Sell
312,495
-50,508
-14% -$10M 0.17% 116
2014
Q3 		$64.7M Sell
363,003
-25,462
-7% -$4.23M 0.16% 120
2014
Q2 		$66.1M Buy
388,465
+63,230
+19% +$9.84M 0.17% 108
2014
Q1 		$40.4M Buy
325,235
+31,572
+11% +$3.84M 0.11% 228
2013
Q4 		$32.6M Buy
293,663
+86,907
+42% +$8.3M 0.1% 290
2013
Q3 		$18.7M Buy
206,756
+58,474
+39% +$5.25M 0.07% 486
2013
Q2 		$12.5M Buy
+148,282
New +$15.4M 0.05% 648

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Guggenheim Capital's AGN Position: Q1 2015 in Review

Guggenheim Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 312,495 shares — an estimated $66.4M sold.

Guggenheim Capital first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $66.4M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Guggenheim Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Guggenheim Capital sold 312,495 Allergan Inc shares in Q1 2015, an estimated $66.4M.
  • Guggenheim Capital first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Guggenheim Capital's Allergan Inc position peaked at $66.4M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Guggenheim Capital's 13F filing for Q1 2015, filed 15 May 2015.